Kabra Drugs Ltd.
| BSE: 524322 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE323K01017 |
| BSE 00:00 | 08 Aug | 4.16 |
0.19 (4.79%) |
OPEN
3.97 |
HIGH
4.16 |
LOW
3.97 |
| NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
| OPEN | 3.97 |
| PREVIOUS CLOSE | 3.97 |
| VOLUME | 4124 |
| 52-Week high | 5.98 |
| 52-Week low | 2.95 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Kabra Drugs Ltd. (KABRADRUGS) - Financial Overview
Particulars ( cr) |
2021 | 2020 | 2019 |
| Net Sales | 0.00 | 0.00 | 0.00 |
| Operating Profit | -0.15 | -0.03 | -0.12 |
| Other Income | 0.00 | 0.02 | 0.01 |
| Interest | 0.00 | 0.00 | 0.01 |
| Depreciation | 0.03 | 0.03 | 0.03 |
| Profit Before Tax | -0.18 | -0.06 | -0.16 |
| Tax | 0.00 | 0.00 | 0.00 |
| Profit After Tax | -0.18 | -0.06 | -0.16 |
| Share Capital | 4.39 | 4.39 | 4.39 |
| Reserves | -4.60 | -4.42 | -4.36 |
| Net Worth | -0.21 | -0.03 | 0.03 |
| Loans | 0.90 | 0.65 | 0.67 |
| Gross Block | 0.17 | 0.17 | 0.17 |
| Investments | 0.00 | 0.00 | 0.00 |
| Cash | 0.01 | 0.01 | 0.01 |
| Debtors | 1.25 | 1.25 | 1.25 |
| Net Working Capital | 0.68 | 0.58 | 0.62 |
| Operating Profit Margin (%) | |||
| Net Profit Margin (%) | |||
| Earning Per Share (Rs) | -0.41 | -0.14 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 |
| Dividend Payout | 0.00 | 0.00 | 0.00 |
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
